Stock

: UK approves coronavirus vaccine made with Oxford, AstraZeneca

AstraZeneca said Wednesday that the coronavirus vaccine developed with Oxford University has been approved by the UK government.

AstraZeneca
AZN,
+ 1.05%

AZN,
+ 1.58%
The COVID-19 vaccine has been approved in the UK for emergency care so that vaccinations can start early in the New Year.

The UK's drug and health products regulator has approved the emergency supplies for the vaccine now known as the COVID-19 vaccine, AstraZeneca.

The approval recommends two doses four to twelve weeks apart.

The UK was the first government to approve the vaccine manufactured by Pfizer
PFE,
+ 0.62%
and BioNTech
BNTX,
+ 0.19%,
and has taken the third highest number of recordings according to Our World in Data Tracker.

The AstraZeneca vaccine came under fire after data showed that it was more effective at half a dose followed by a full dose than at two full doses. AstraZeneca said additional safety and efficacy data for the vaccine will continue to come from ongoing clinical trials.

The advantage of the AstraZeneca vaccine over the Pfizer vaccine is that it can be stored at normal refrigerated temperatures instead of requiring super cold storage. AstraZeneca plans to distribute up to 3 billion vaccines in developing countries.

Related Articles